Cargando…

Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment

Closely linked to Alzheimer’s disease (AD), the pathological spectrum of vascular cognitive impairment (VCI) is known to be wide and complex. Considering that multiple instead of a single targeting approach is considered a treatment option for such complicated diseases, the multifaceted aspects of m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Na Kyung, Kim, Hyeongseop, Chang, Jong Wook, Jang, Hyemin, Kim, Hunnyun, Yang, Jehoon, Kim, Jeyun, Son, Jeong Pyo, Na, Duk L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432487/ https://www.ncbi.nlm.nih.gov/pubmed/32752272 http://dx.doi.org/10.3390/ijms21155524

Ejemplares similares

Heterogeneous Disease Progression in a Mouse Model of Vascular Cognitive Impairment
por: Lee, Na Kyung, et al.
Publicado: (2020)

Induced neural stem cells from human patient-derived fibroblasts attenuate neurodegeneration in Niemann-Pick type C mice
por: Hong, Saetbyul, et al.
Publicado: (2021)

Intrathecal Injection in a Rat Model: A Potential Route to Deliver Human Wharton’s Jelly-Derived Mesenchymal Stem Cells into the Brain
por: Kim, Hyeongseop, et al.
Publicado: (2020)

Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma
por: Hwang, Jung Won, et al.
Publicado: (2021)

Intracerebroventricular Administration of Human Umbilical Cord Blood—Derived Mesenchymal Stem Cells Induces Transient Inflammation in a Transgenic Mouse Model and Patients with Alzheimer’s Disease
por: Myeong, Su Hyeon, et al.
Publicado: (2022)

Cerebrospinal fluid from Alzheimer’s disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer’s disease
por: Lee, Jeongmin, et al.
Publicado: (2019)

Intra-Arterially Delivered Mesenchymal Stem Cells Are Not Detected in the Brain Parenchyma in an Alzheimer’s Disease Mouse Model
por: Lee, Na Kyung, et al.
Publicado: (2016)

Identifying genetic variants for amyloid β in subcortical vascular cognitive impairment
por: Kim, Hang-Rai, et al.
Publicado: (2023)

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment
por: Jang, Hyemin, et al.
Publicado: (2018)

Cortical neuroanatomical changes related to specific neuropsychological deficits in subcortical vascular cognitive impairment
por: Kang, Sung Hoon, et al.
Publicado: (2021)

Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer’s Disease
por: Lee, Na Kyung, et al.
Publicado: (2022)

Linguistic, visuospatial, and kinematic writing characteristics in cognitively impaired patients with beta-amyloid deposition
por: An, Seo Kyung, et al.
Publicado: (2023)

Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase I clinical trial
por: Kim, Hee Jin, et al.
Publicado: (2021)

Magnetic Resonance Imaging of Ferumoxytol-Labeled Human Mesenchymal Stem Cells in the Mouse Brain
por: Lee, Na Kyung, et al.
Publicado: (2016)

A Comparison of Immune Responses Exerted Following Syngeneic, Allogeneic, and Xenogeneic Transplantation of Mesenchymal Stem Cells into the Mouse Brain
por: Hwang, Jung Won, et al.
Publicado: (2020)

Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Distinctive Temporal Trajectories of Alzheimer’s Disease Biomarkers According to Sex and APOE Genotype: Importance of Striatal Amyloid
por: Kim, Jun Pyo, et al.
Publicado: (2022)

Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment
por: Jung, Young Hee, et al.
Publicado: (2020)

Distinct effects of cholesterol profile components on amyloid and vascular burdens
por: Kang, Sung Hoon, et al.
Publicado: (2023)

Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer’s disease
por: Choi, Yejoo, et al.
Publicado: (2023)

Wharton’s Jelly-Derived Mesenchymal Stem Cells Reduce Fibrosis in a Mouse Model of Duchenne Muscular Dystrophy by Upregulating microRNA 499
por: Park, Sang Eon, et al.
Publicado: (2021)

Relationships between educational attainment, hypertension, and amyloid negative subcortical vascular dementia: The brain-battering hypothesis
por: Hwangbo, Song, et al.
Publicado: (2022)

Distinctive Mediating Effects of Subcortical Structure Changes on the Relationships Between Amyloid or Vascular Changes and Cognitive Decline
por: Jung, Na-Yeon, et al.
Publicado: (2021)

Ethionamide Preconditioning Enhances the Proliferation and Migration of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Lee, Na-Hee, et al.
Publicado: (2020)

Estrogen attenuates the spondyloarthritis manifestations of the SKG arthritis model
por: Jeong, Hyemin, et al.
Publicado: (2017)

Agouti Related Peptide Secreted Via Human Mesenchymal Stem Cells Upregulates Proteasome Activity in an Alzheimer’s Disease Model
por: Lee, Na Kyung, et al.
Publicado: (2017)

White Matter Lesions Predominantly Located in Deep White Matter Represent Embolic Etiology Rather Than Small Vessel Disease
por: Jung, Young Hee, et al.
Publicado: (2023)

Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer’s Disease, Pure Subcortical Vascular Dementia, and Mixed Dementia
por: Jang, Hyemin, et al.
Publicado: (2017)

Cortical neuroanatomical changes related to specific language impairments in primary progressive aphasia
por: Kang, Sung Hoon, et al.
Publicado: (2022)

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers
por: Jang, Hyemin, et al.
Publicado: (2019)

Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
por: Lee, Jongmin, et al.
Publicado: (2020)

Classification and prediction of cognitive trajectories of cognitively unimpaired individuals
por: Kim, Young Ju, et al.
Publicado: (2023)

Staging and quantification of florbetaben PET images using machine learning: impact of predicted regional cortical tracer uptake and amyloid stage on clinical outcomes
por: Kim, Jun Pyo, et al.
Publicado: (2019)

PT598. Therapeutic potential of mesenchymal stem cells from different sources
por: Lee, Jeongmin, et al.
Publicado: (2016)

PT577. Distribution of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs) in the Alzheimer’s Disease Transgenic Mouse after a Single Intravenous Injection
por: Park, Sang Eon, et al.
Publicado: (2016)

Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study
por: Kim, Yeo Jin, et al.
Publicado: (2017)

The effects of imaging markers on clinical trajectory in cerebral amyloid angiopathy: a longitudinal study in a memory clinic
por: Jang, Hyemin, et al.
Publicado: (2023)

Social Event Memory Test (SEMT): A Video-based Memory Test for Predicting Amyloid Positivity for Alzheimer’s Disease
por: Kim, Ko Woon, et al.
Publicado: (2018)

Clinical outcomes of increased focal amyloid uptake in individuals with subthreshold global amyloid levels
por: Kim, Jaeho, et al.
Publicado: (2023)

Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers
por: Jung, Young Hee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lqjndhbtmom45ebd9jr6r599q7